Internal Medicine, Hematology & Oncology · Camden, NJ
NPI
1861673089
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
2 Cooper Plz
Camden, NJ, 08103
Phone (855) 632-2667
Groups this clinician bills Medicare through
Medicare paid, 2024
$54K
968 services
Medicare patients, 2024
241
Average age 71
Drug cost, 2024
$724K
614 prescriptions
Company payments, 2025
$63.1
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Polina Khrizman was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 285 times for 132 patients. In total Polina Khrizman billed 968 services in 17 codes, and Medicare paid $54K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-06-09.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 285 | 132 | $13.50 | $3,848 |
| 99213 Office E&M - Established | Facility | 126 | 79 | $52.31 | $6,592 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 109 | 49 | $13.57 | $1,479 |
| 99215 Office E&M - Established | Facility | 108 | 69 | $113.01 | $12K |
| 99214 Office E&M - Established | Facility | 78 | 54 | $79.98 | $6,238 |
| 99213 Office E&M - Established | Office | 61 | 38 | $46.42 | $2,831 |
| 99205 Office E&M - New | Facility | 39 | 39 | $141.67 | $5,525 |
| 99214 Office E&M - Established | Office | 38 | 27 | $80.30 | $3,051 |
| 99215 Office E&M - Established | Office | 32 | 23 | $117.30 | $3,754 |
| 99232 Hospital E&M - Subsequent | Facility | 27 | 20 | $64.06 | $1,730 |
| 99222 Hospital E&M - Initial | Facility | 24 | 24 | $108.17 | $2,596 |
| 99205 Office E&M - New | Office | 15 | 15 | $149.19 | $2,238 |
By year: 2022 $68K for 877 services; 2023 $56K for 697 services; 2024 $54K for 968 services.
Medicare prescription drug claims, 2024
In 2024, the drug Polina Khrizman prescribed most often to Medicare patients was Prochlorperazine Maleate, with 123 prescriptions and refills. In total Polina Khrizman wrote 614 Medicare prescriptions that cost $724K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prochlorperazine Maleate Generic | 123 | 123 | 74 | $1,131 |
| Ondansetron Odt Ondansetron | 120 | 122 | 81 | $1,080 |
| Dexamethasone Generic | 80 | 80 | 24 | $448 |
| Eliquis Apixaban | 39 | 41 | 11 | $24K |
| Imatinib Mesylate Generic | 28 | 34 | Under 11 | $45K |
| Gabapentin Generic | 27 | 27 | Under 11 | $210 |
| Potassium Chloride Generic | 25 | 25 | Under 11 | $165 |
| Tagrisso Osimertinib Mesylate | 24 | 24 | Under 11 | $504K |
| Mirtazapine Generic | 17 | 27 | Under 11 | $601 |
| Oxycodone Hcl Generic | 14 | 14 | Under 11 | $183 |
| Mesnex Mesna | 13 | 13 | Under 11 | $26K |
| Everolimus Generic | 13 | 13 | Under 11 | $22K |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 12 | 12 | Under 11 | $123 |
Brand drugs: 93 claims; generic drugs: 521 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Polina Khrizman $63.1 ($63.1 in general payments such as food, travel and fees) from 2 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $63.1.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 2 | $63.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.